This ANZAC Day 2023, Australian Health Journal releases an interview with Group Captain Kath Stein MACN, Director of Defence Force Nursing with the Royal Australian Air Force.
She talks about many masks, aside from PPE, that leadership and all nurses need to wear. Currently there is work underway on a new capability description on what a nurse brings to every level in the nursing defence structure. The advice Group Captain Stein, imparts for new recruits and those interested in joining Defence Force Nursing is to take every opportunity that arises. This is evident in her progression through her career.
Group Captain Stein joined the Air Force in March 1991 through the Undergraduate Scheme. Following her graduation from University she consolidated her clinical training in the Graduate Program at Fremantle Hospital.
In the years that have followed she has served in health facilities including Number 3 RAAF Hospital, Health Services Flights Pearce and Tindal with operational experience on exercises and deployments. This health experience supported her health planning role in Headquarters 395 Expeditionary Combat Support Wing and varying policy and governance roles in Strategic Policy and Intelligence Group, Joint Health Command and Air Force Headquarters. She was privileged to Command Joint Health Unit Northern New South Wales and is the current Director of Defence Force Nursing.
Group Captain Stein’s professional development activities have included the USAF Flight Nurse Course and tertiary studies to specialise in Trauma Nursing and Emergency Management. She recently Graduated from the Australian Institute of Company Directors and has served as a Director on the Board for a Not for Profit Organisation making a difference in Mental Health Services for the community. Her interests outside of work include supporting her childrens’ sporting pursuits, catching up with friends and community service. She has two teenage boys and indulges one very spoilt puppy, Alfie.
Credits:
Australian College of Nursing (National Nursing Forum 2022, Darwin),
Adjunct Professor Kylie Ward FACN, CEO ACN
-
Awareness, diagnosis and treatment of Congenital Hypothyroidism
Australian Health Journal spoke to Associate Professor MIchelle Jack about congenital hypothyroidism and newborn screening and her concerns in the varying thresholds for across different states in Australia. Despite the existence of newborn screening programs since the 1970s, there is still controversy surrounding the appropriate screening levels. Congenital hypothyroidism, affecting about one in 3500 infants, can lead to severe intellectual and physical impairment if not diagnosed early. The condition is mainly caused by the thyroid gland’s failure to develop properly, resulting in insufficient thyroid hormone production.
-
Implementing improvements in referral management and demand
Nalani Cox joined Gold Coast Health in 2019 as a Nurse Manager focused on improving referral management processes within the outpatient environment through the implementation of the Clinical Prioritisation Criteria. This work became a focus point for the organisation in 2020 when Nalani led an organisational wide change project introducing Smart Referrals, Refer Your Patient website and HealthPathways which has culminated in her position as the ADON of the Referral Strategy and Performance Department.
-
Cardiovascular Disease Risk Guidance and Calculator get long overdue update
Cardiovascular disease (CVD) is responsible for significant morbidity and premature mortality in Australia. Ischaemic heart disease was the leading cause of death in 2020 and cerebrovascular disease was the third most common cause of death.
As the first major update to Australian CVD risk assessment guidelines in over a decade, the 2023 Australian Guideline for assessing and managing cardiovascular disease risk and associated Aus CVD Risk Calculator reflect the latest evidence on assessing, communicating, and managing CVD risk. Developed using Australian-specific data and the latest evidence, it supersedes the 2012 Guidelines for the management of absolute cardiovascular disease risk.
